Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Low-intensity pulsed ultrasound upregulates pro-myelination indicators of Schwann cells enhanced by co-culture with adipose-derived stem cells.
Active immunotherapy may delay disability in progressive MS.
Oligodendrocyte differentiation.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
GDNF Enhances Therapeutic Efficiency of Neural Stem Cells-Based Therapy in Chronic Experimental Allergic Encephalomyelitis in Rat.
Metagenomic Analysis of Cerebrospinal Fluid from Patients with Multiple Sclerosis.
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
In vivo amyloid aggregation kinetics tracked by time-lapse confocal microscopy in real-time.
The importance of a multi-disciplinary perspective and patient activation programmes in MS management.
Physical Activity and Its Correlates in Youth with Multiple Sclerosis.
Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
[Immune-mediated neuropathies].
Immune cell-specific transcriptional profiling highlights distinct molecular pathways controlled by Tob1 upon experimental autoimmune encephalomyelitis.
Melatonin reverses H-89 induced spatial memory deficit: Involvement of oxidative stress and mitochondrial function.
Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.
SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome.
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Assisted suicide and the law.
[Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
Is physical exercise a multiple sclerosis disease modifying treatment?
Normal Molecular Specification and Neurodegenerative Disease-Like Death of Spinal Neurons Lacking the SNARE-Associated Synaptic Protein Munc18-1.
Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
Arzerra receives approval in Japan
Cytokine-induced release of ceramide-enriched exosomes as a mediator of cell death signaling in an oligodendroglioma cell line.
Pages
« first
‹ previous
…
749
750
751
752
753
754
755
756
757
…
next ›
last »